Executing Change: Pharma’s Emerging-Market Strategies in Asia Pacific


September 1, 2010
SKU: DECR2849114
License type:
Delcath Systems, Inc. (DCTH) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Delcath Systems, Inc. (Delcath) is a US-based development stage, specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic  |  read more...
$750.00
Hadasit Medical Research Services & Development Ltd - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Hadasit Medical Research Services & Development Ltd (Hadasit Ltd) is a biomedical technology company. It provides, promotes and commercializeS pre-clinical and clinical research and development capabilities through product licensing, establishing start-up companies and collaboration with  |  read more...
$750.00
Mystic Pharmaceuticals, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Mystic Pharmaceuticals, Inc. (Mystic) is a pharmaceutical service company. The company develops and commercializes drug delivery systems. It offers services such as device manufacturing, drug compounding, sterilization filtration, aseptic form fill seal blister production, packaging  |  read more...
$750.00
Randox Laboratories Ltd. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Randox Laboratories Ltd. (Randox) is a pharmaceutical and healthcare company. It develops and manufactures diagnostic kits for biochemistry laboratories. Its major product categories include biochip analyzers, biochip immunoassays, biochip molecular diagnostics, cardiovascular biomarkers and regents,  |  read more...
$750.00
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals
5/15/2013 | published by: GlobalData
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals” report is an essential source of data and trend  |  read more...
$1,000.00
Consumer Health in Hong Kong, China
5/17/2013 | published by: Euromonitor International
Consumer Health in Hong Kong, China The total consumer health industry saw a healthy 7% growth in 2012 to reach HK$6.6 billion. It is supported by a strong sense of health consciousness amongst Hong Kong people.  |  read more...
$2,400.00
AcelRx Pharmaceuticals, Inc. (ACRX) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary AcelRx Pharmaceuticals, Inc. (AcelRx) is a specialty pharmaceutical company. It focuses on the development and marketing of novel therapies for the diagnosis of pain and other related disorders. The company's pipeline product portfolio includes ARX-01,  |  read more...
$750.00
AdvanDx, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary AdvanDx (AdvanDx) is a pharmaceutical and healthcare company. The company develops and markets molecular-based in vitro diagnostic tests for the diagnosis and prevention of infectious diseases. The company’s products includes development of peptide nucleic acid  |  read more...
$750.00
Antares Pharma, Inc. (ATRS) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Antares Pharma, Inc. (Antares Pharma) is a specialty pharmaceutical company, which focuses on the self-injection pharmaceutical drugs and technologies and topical gel-based products. The company is focused on topical gel-based products and self-injection pharmaceutical products  |  read more...
$750.00
Cytokine PharmaSciences, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Cytokine PharmaSciences, Inc. (CPSI) is a biopharmaceutical company. The company develops drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer .It manufactures  |  read more...
$750.00